Subscribe to RSS
DOI: 10.1055/s-2007-1000841
Investigation of the Reaction of o-Aminonitriles with Ketones: A New Modification of Friedländer Reaction and Structures of Its Products
Publication History
Publication Date:
11 December 2007 (online)
Abstract
A new modification of the Friedländer reaction is described and the new byproduct obtained from the reaction of o-aminonitriles and ketones was found to be 2,3-dihydroquinazolin-4(1H)-one. The mechanism probably involved the formation of an intermediate oxazine, via the Pinner reaction and its transformation into new products via the Dimroth rearrangement.
Key words
Friedländer reactions - cyclizations - spiro compounds - rearrangements - molecular recognition
-
1a
Taylor EC.McKillop A. The Chemistry of Cyclic Enaminonitriles and o-Aminonitrile Wiley; New York: 1970. -
1b
Erian AW. Chem. Rev. 1993, 93: 1991 -
2a
Varala R.Enugala R.Adapa SR. Synthesis 2006, 3825 -
2b
Cheng CC.Yan SJ. Org. React. (N. Y.) 1982, 28: 37 -
2c
Madrid PB.Sherrill J.Lion AP.Weisman JL.DeRisi JL.Guy RK. Bioorg. Med. Chem. Lett. 2005, 15: 1015 - 3
Abd El-Wahab AHF. Acta Pharm. 2002, 54: 269 -
4a
Rosowsky A.Chen H. J. Org. Chem. 2001, 66: 7522 -
4b
Mohareb RM.Al-Omran FA. Monatsh. Chem.. 2002, 133: 1443 -
4c
Wiklund P.Bergman J. Org. Biomol. Chem. 2003, 1: 467 -
5a
Roth GA.Tai JJ. J. Heterocycl. Chem. 1996, 33: 2051 -
5b
Grubs GS,Zhi L,Jones TK,Marschke KB, andTegley CM. inventors; PCT Int. Appl., WO0066560. -
6a
Mizuno T.Okamoto N.Ho T.Miyata T. Heteroat. Chem. 2000, 11: 428 -
6b
Mizuno T. Kagaku to Kogyo 2002, 76: 431 ; Chem. Abstr. 2002, 138, 256866j -
6c
Yoshida T. inventors; Jpn. Patent, JP200491403. -
6d
Mizuno T.Iwai T.Ishino Y. Tetrahedron Lett. 2004, 45: 7073 -
6e
Nourry A.Legoupy S.Huet F. Tetrahedron Lett. 2007, 48: 6014 -
7a
Zhichkin P.Beer CMC.Rennells WM.Fairfax DJ. Synlett 2006, 379 -
7b
Ryabukhin SV.Volochnyuk DM.Plaskon AS.Naumchik VS.Tolmachev AA. Synthesis 2007, 1214 -
7c
Antoniow S.Witt D. Synthesis 2007, 363 -
7d
Yadav JS.Reddy BVS.Premalatha K. Synlett 2004, 963 -
7e
Palimkar SS.Siddiqui SA.Daniel T.Lahoti RJ.Srinivasan KV. J. Org. Chem. 2003, 68: 9371 -
7f
Patteux C.Levacher V.Dupas G. Org. Lett. 2003, 5: 3061 -
7g
Dormer PG.Eng KK.Farr RN.Humphrey GR.McWilliams JC.Reider PJ.Sager JW.Volante RP. J. Org. Chem. 2003, 68: 467 -
7h
Gladiali S.Chelucci G.Mudadu MS.Gastaut MA.Thunmet PR. J. Org. Chem. 2001, 66: 400 -
7i
Boger DL.Chen J.-H. J. Org. Chem. 1995, 60: 7369 -
7j
Riesgo EC.Jin X.Thummel RP. J. Org. Chem. 1996, 61: 3017 -
8a
Grigis NS.Pederson EB. Synthesis 1985, 547 -
8b
Schredl M.Hornung O.Regen F.Albrecht N.Danker-Hopfe H.Heuser I. Pharmacopsych. 2006, 6 -
8c
Engger SA.Levy R.Sahakian BJ. Lancet 1991, 337: 989 -
8d
Summers WK.Majovski LV.Marsh GMN. New Engl. J. Med. 1996, 315: 1241 -
8e
Proctor GR.Harvey AL. Curr. Med. Chem. 2000, 7: 295 -
8f
Li JR.Zhou XW.Cheng P.Guo YJ. J. Beijing Inst. Technol. 2002, 11: 375 -
9a
Carlier PR.Han YF.Chow ESH.Li CPL.Wang H.Lieu TX.Wong HS.Pang YP. Bioorg. Med. Chem. 1999, 7: 351 -
9b
Camps P.Formosa X.Muňoz-Torrero DM.Petrignet J.Badia A.Clos MV. J. Med. Chem. 2005, 48: 1701 -
9c
Hu MK.Wu LJ.Hsiao G.Yen MH. J. Med. Chem. 2002, 45: 2277 -
9d
Haviv HR.Wong DM.G reenblatt HM.Carlier PR.Han YF.Pang YP.Silman I.Sussman JL. J. Am. Chem. Soc. 2005, 127: 11029 -
10a
Sakurai A.Midorikawa N. Bull. Chem. Soc. Jpn. 1967, 40: 1680 -
10b
Sakurai A.Midorikawa N. Bull. Chem. Soc. Jpn. 1968, 41: 430 -
10c
Shi DQ.Zhang S.Zhuang QY.Wang XS.Tu SJ.Hu H. Chin. J. Org. Chem. 2003, 23: 1419 -
12a
Su WK.Yang BB. J. Chem. Res. 2002, 604 -
12b
Cai GP.Xu XL.Li ZF.Weber WP.Lu P. J. Heterocycl. Chem. 2002, 39: 1271 -
12c
Yoo CL.Fettinger JC.Kurth MJ. J. Org. Chem. 2005, 70: 6941 -
14a
Pinner A.Klein F. Ber. Dtsch. Chem. Ges. 1877, 10: 1899 -
14b
Siskos AP.Hill AM. Tetrahedron Lett. 2003, 44: 789 - 15
Rozhkov VY.Batog LV.Shevtsova EK.Struchkova MI. Mendeleev Commun. 2004, 76
References and Notes
Typical Procedure for Preparation of Products 2 and 4: o-Aminonitrile 1 (1.5 mmol), cyclohexanone (1.7 mmol), anhyd zinc chloride (1.6 mmol) and DMF (10 mL) were added into a 50-mL flask. The reaction mixture was refluxed for 2 h (monitored by TLC). Then the mixture was diluted with H2O and titrated to pH 12-13 by 20% NaOH. After filtration, the solid was dissolved in THF, the organic phase obtained was combined with the extracted component of filtrate (using EtOAc) and evaporated in vacuo, and then chromatographed (Merck, 200-300 mesh, EtOAc-PE, 1:2) to afford product 2 and 4.Selected data for compounds 2, 4 and 8:14-(3-Nitrophenyl)-9,10,11,12-tetrahydro-14 H -naphtho[1′,2′:5,6]pyrano[2,3- b ]quinolin-13-amine (2a): yellow solid; mp 287-289 °C. IR (KBr): 3450, 3364, 2935, 1640, 1607, 1573, 1523, 1445, 1348, 1232 cm-1. 1H NMR: (400 MHz, CDCl3): δ = 1.80-1.86 (m, 4 H, CH2), 2.28-2.42 (m, 2 H, CH2), 2.82 (m, 2 H, CH2), 4.42 (s, 2 H, NH2), 5.76 (s, 1 H, CH), 7.34-7.40 (q, J = 8.0 Hz, 2 H, ArH), 7.46-7.51 (m, J = 8.0 Hz, 2 H, ArH), 7.72 (d, J = 7.9 Hz, 1 H, ArH), 7.79 (t, J = 7.9 Hz, 2 H, ArH), 7.98 (m, J = 2.0, 8.0 Hz, 2 H, ArH), 8.38 (t, J = 2.0 Hz, 1 H, ArH). 13C NMR (100 MHz, CDCl3): δ = 22.3, 22.4, 22.9, 32.4, 37.9, 99.3, 113.2, 114.9, 118.5, 121.8, 122.1 (2 × C), 124.3, 127.1, 128.9, 129.8, 129.9, 130.5, 130.8, 134.3, 145.6, 148.0, 149.0, 150.3, 154.5, 154.8. MS (ESI): m/z = 424.3 [M + H+]. Anal. Calcd for C26H21N3O3: C, 73.74; H, 5.00; N, 9.92. Found: C, 73.60; H, 5.05; N, 9.75.8,9,12-Trihydro-9,9-pentamethylene-12-(3-nitrophenyl)-11 H -naphtho[1′,2′:5,6]pyrano[2,3- d ]pyrimidin-11 (10 H )-one (4a): yellow solid; mp 275-278 °C. IR (KBr): 3187, 2937, 1659, 1630, 1527, 1349, 1227 cm-1. 1H NMR (400 MHz, DMSO-d 6): δ = 1.22 (m, 1 H, CH2), 1.38 (m, 4 H, CH2), 1.66 (m, 4 H, CH2), 1.76 (m, 1 H, CH2), 5.76 (s, 1 H, CH), 7.23 (s, 1 H, NH), 7.43-7.52 (m, J = 7.8 Hz, 4 H, ArH), 7.58 (s, 1 H, NH), 7.63 (d, J = 7.8 Hz, 1 H, ArH), 7.96 (m, J = 1.8, 7.8 Hz, 4 H, ArH), 8.12 (t, J = 1.8 Hz, 1 H, ArH). 13C NMR (100 MHz, DMSO-d 6): δ = 20.7, 21.1, 24.7, 34.3, 36.0, 36.3, 67.1, 81.6, 116.9, 117.0, 121.1, 121.9, 123.3, 125.0, 127.4, 128.6, 129.6, 129.9, 130.6, 130.8, 134.1, 147.6, 147.7, 148.8, 154.8, 165.5. MS (ESI): m/z = 442.3 [M + H+]. Anal. Calcd for C26H23N3O4: C, 70.73; H, 5.25; N, 9.52. Found: C, 70.45; H, 5.22; N, 9.61.6-Chloro-2,2-pentamethylene-1,2-dihydroquinazolin-4 (3 H )-one (8a): light yellow solid; mp 232-233 °C. IR (KBr): 3358, 3173, 2934, 2855, 1643, 1612, 1493, 825 cm-1. 1H NMR (DMSO-d 6): δ = 1.23-1.73 (m, 10 H, CH2), 6.63 (dd, J = 2.0, 8.0 Hz, 1 H, ArH), 6.86 (d, J = 2.0 Hz, 1 H, ArH), 6.90 (s, 1 H, NH), 7.54 (d, J = 8.0 Hz, 1 H, ArH), 8.05 (s, 1 H, NH). MS (ESI): m/z (%) = 264.2 (100) [M + H]+. Anal. Calcd for C13H15ClN2O (252.1): C, 62.28; H, 6.03; N, 14.14. Found: C, 62.19; H, 5.92; N, 14.11.2,2-Butamethylene-6-nitro-1,2-dihydroquinazolin-4 (3 H )-one (8b): mp 281-283 °C. IR (KBr): 3319, 3180, 2912, 1672, 1619, 1534, 1310 cm-1. 1H NMR (DMSO-d 6): δ = 1.67-1.88 (m, 8 H, C4H8), 6.82 (d, J = 8.0 Hz, 1 H, ArH), 8.10 (dd, J = 2.4, 8.0 Hz, 1 H, ArH), 8.30 (s, 1 H, NH), 8.42 (d, J = 2.4 Hz, 1 H, ArH), 8.56 (s, 1 H, NH). 13C NMR (DMSO-d 6): δ = 21.90 (2 × C), 40.15 (2 × C), 77.32, 112.31, 114.14, 124.11, 128.62, 136.68, 151.63, 161.21. MS (ESI): m/z (%) = 248.2 (100) [M + H]+. Anal. Calcd for C12H13N3O3: C, 58.29; H, 5.30; N, 16.99. Found: C, 58.33; H, 5.31; N, 17.08.
13CCDC 660416 (4a) and CCDC 667600(4b) contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/data_request/cif.
16This new conversion is abbreviated as PDF conversion, which means a new conversion from Pinner to Dimroth rearrangement in the Friedländer reaction.